Maxipime

In the US, Maxipime (cefepime systemic) is a member of the drug class fourth generation cephalosporins and is used to treat Bacteremia, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Nosocomial Pneumonia, Pneumonia, Skin and Structure Infection, Skin Infection and Urinary Tract Infection.

US matches:

• Maxipime


• Maxipime ADD-Vantage

Ingredient matches for Maxipime

Cefepime

Cefepime is reported as an ingredient of Maxipime in the following countries:

• Latvia


• Taiwan

Cefepime Hydrochloride (a derivative of Cefepime) is reported as an ingredient of Maxipime in the following countries:

• Australia


• Austria


• Belgium


• Bosnia & Herzegowina


• Canada


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Estonia


• Finland


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Italy


• Japan


• Lithuania


• Luxembourg


• Malaysia


• Mexico


• New Zealand


• Oman


• Peru


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Turkey


• United States


• Venezuela


• Vietnam

International Drug Name Search